$1.46 2.1%
DRIO Stock Price vs. AI Score (Last 150 days)
Data gathered: July 15

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About DarioHealth

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand.


DarioHealth
Price $1.46
Target Price Sign up
Volume 13,860
Market Cap $43M
Year Range $1 - $2.55
Dividend Yield 0%
Revenue per Employee $76,266
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '245.8M18M2.4M-7.2M-17M-0.200
Q4 '232.9M16M130,000-14M-13M-0.500
Q3 '233.5M13M610,000-16M-14M-0.490
Q2 '236.2M15M2.1M-17M-13M-0.580
Q1 '236.1M15M3.2M-13M-11M-0.450

Insider Transactions View All

Raphael Erez filed to buy 30 shares at $1000.
May 8 '23
KAPLAN JON H. filed to buy 30 shares at $1000.
May 8 '23
Shaked Yoav filed to buy 40 shares at $1000.
May 8 '23
Matheis Dennis filed to buy 50 shares at $1000.
May 8 '23
Raphael Erez filed to sell 1,112,059 shares at $6.2.
January 18 '23

What is the Market Cap of DarioHealth?

The Market Cap of DarioHealth is $43M.

How Many People Work at DarioHealth?

As of our latest update, DarioHealth employed approximately 241 people worldwide. However, it's important to note that DarioHealth's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is DarioHealth's revenue per employee?

$76,266. To calculate DarioHealth's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of DarioHealth?

Currently, the price of one share of DarioHealth stock is $1.46.

How can I analyze the DRIO stock price chart for investment decisions?

The DRIO stock price chart above provides a comprehensive visual representation of DarioHealth's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling DarioHealth shares. Our platform offers an up-to-date DRIO stock price chart, along with technical data analysis and alternative data insights.

Does DRIO offer dividends to its shareholders?

As of our latest update, DarioHealth (DRIO) does not offer dividends to its shareholders. Investors interested in DarioHealth should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of DarioHealth?

Some of the similar stocks of DarioHealth are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.